Konrad-Martin D - Search Results

1

Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.

Garinis AC, Poling GL, Rubenstein RC, Konrad-Martin D, Hullar TE, Baguley DM, Burrows HL, Chisholm JA, Custer A, Hawe LD, Hunter LL, Marras TK, Ortiz CE, Petersen L, Steyger PS, Winthrop K, Zettner EM, Clark K, Hungerford M, Vachhani JJ, Brewer CC. Garinis AC, et al. Among authors: konrad martin d. Am J Audiol. 2021 Oct 11;30(3S):800-809. doi: 10.1044/2021_AJA-21-00031. Epub 2021 Sep 22. Am J Audiol. 2021. PMID: 34549989 Free PMC article.

2

Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.

Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS, Bratt GW, Fausti SA. Konrad-Martin D, et al. J Am Acad Audiol. 2010 May;21(5):301-14; quiz 357. doi: 10.3766/jaaa.21.5.3. J Am Acad Audiol. 2010. PMID: 20569665 Free PMC article.

3

Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.

Dille MF, Konrad-Martin D, Gallun F, Helt WJ, Gordon JS, Reavis KM, Bratt GW, Fausti SA. Dille MF, et al. J Am Acad Audiol. 2010 Jun;21(6):409-17. doi: 10.3766/jaaa.21.6.6. J Am Acad Audiol. 2010. PMID: 20701838 Free PMC article.

4

Multivariate DPOAE metrics for identifying changes in hearing: perspectives from ototoxicity monitoring.

Konrad-Martin D, Reavis KM, McMillan GP, Dille MF. Konrad-Martin D, et al. Int J Audiol. 2012 Feb;51 Suppl 1(Suppl 1):S51-62. doi: 10.3109/14992027.2011.635713. Int J Audiol. 2012. PMID: 22264063 Free PMC article.

5

Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.

McMillan GP, Konrad-Martin D, Dille MF. McMillan GP, et al. Int J Audiol. 2012 Sep;51(9):689-96. doi: 10.3109/14992027.2012.688143. Epub 2012 Jun 7. Int J Audiol. 2012. PMID: 22676700 Free PMC article.

6

Development and validation of a cisplatin dose-ototoxicity model.

Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D. Dille MF, et al. J Am Acad Audiol. 2012 Jul-Aug;23(7):510-21. doi: 10.3766/jaaa.23.7.3. J Am Acad Audiol. 2012. PMID: 22992258 Free PMC article.

7

ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.

Dille MF, Ellingson RM, McMillan GP, Konrad-Martin D. Dille MF, et al. J Am Acad Audiol. 2013 Oct;24(9):769-81. doi: 10.3766/jaaa.24.9.2. J Am Acad Audiol. 2013. PMID: 24224985 Free PMC article.

8

A Store-and-Forward Tele-Audiology Solution to Promote Efficient Screenings for Ototoxicity during Cisplatin Cancer Treatment.

Dille MF, McMillan GP, Helt WJ, Konrad-Martin D, Jacobs P. Dille MF, et al. J Am Acad Audiol. 2015 Oct;26(9):750-60. doi: 10.3766/jaaa.15028. J Am Acad Audiol. 2015. PMID: 26415968 Free PMC article.

9

Serial Monitoring of Otoacoustic Emissions in Clinical Trials.

Konrad-Martin D, Poling GL, Dreisbach LE, Reavis KM, McMillan GP, Lapsley Miller JA, Marshall L. Konrad-Martin D, et al. Otol Neurotol. 2016 Sep;37(8):e286-94. doi: 10.1097/MAO.0000000000001134. Otol Neurotol. 2016. PMID: 27518137 Review.

10

Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.

Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D. Garinis AC, et al. Int J Audiol. 2018 Sep;57(sup4):S19-S24. doi: 10.1080/14992027.2017.1381769. Epub 2017 Oct 5. Int J Audiol. 2018. PMID: 28978238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page